Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy

NCT05512130 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05512130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05512130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Unknown status
Start date
August 17, 2022
Completion date
June 30, 2023
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy